Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tarceva (erlotinib) in combination with capecitabine for metastatic pancreatic cancer has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: Grupo Gallego de Investigaciones Oncologicas | Conditions: Metastatic Adenocarcinoma of the Pancreas | Phase 2 | Status: COMPLETED